According to Santen Pharmaceutical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.70. At the end of 2024 the company had a P/S ratio of 1.79.
Year | P/S ratio | Change |
---|---|---|
2024 | 1.79 | 5.21% |
2023 | 1.70 | 11.23% |
2022 | 1.53 | -26.3% |
2021 | 2.08 | -27.28% |
2020 | 2.85 | -16.78% |
2019 | 3.43 | 22.05% |
2018 | 2.81 | -14.8% |
2017 | 3.30 | 17.94% |
2016 | 2.80 | -34.73% |
2015 | 4.29 | 38.23% |
2014 | 3.10 | 12.95% |
2013 | 2.74 | 24.01% |
2012 | 2.21 | -9.33% |
2011 | 2.44 | 2.04% |
2010 | 2.39 | 3.76% |
2009 | 2.31 |